Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00318890

Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck

A Phase I/II Trial of Induction Cisplatin and Docetaxel Followed by Concomitant Docetaxel/Radiotherapy With Subcutaneous Amifostine for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Sponsor: Aventis Pharmaceuticals

Conditions Cancer of Head and Neck Head Cancer Head and Neck Cancer Neck Cancer Neck Neoplasms

Interventions Amifostine Cisplatin Docetaxel Radiotherapy

Updated 7 times since 2017 Last updated: Feb 2, 2019 Started: Oct 31, 2002 Primary completion: Apr 30, 2007 Completion: Dec 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00318890, this PHASE1/PHASE2 trial focuses on Cancer of Head and Neck and Head Cancer and remains completed. Sponsored by Aventis Pharmaceuticals, it has been updated 7 times since 2002, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Mar 2019 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Mar 2019 [monthly]

Completed PHASE1_PHASE2

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Oct 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aventis Pharmaceuticals
University of Alabama at Birmingham

Data source: University of Alabama at Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Birmingham, United States